South Florida Infectious Diseases P A is categorized under Doctors in Pompano Beach, FL and active since 2006.
South Florida Infectious Diseases P A was established in 2006, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Carlos Cohen at the company’s single location by writing to 1237 Hillsboro Mile # 101, Pompano Beach, Florida FL 33062 or by phoning (561) 381-3443. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | South Florida Infectious Diseases P A |
| Contact Person: | Carlos Cohen |
| Address: | 1237 Hillsboro Mile # 101, Pompano Beach, Florida 33062 |
| Phone Number: | (561) 381-3443 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
South Florida Infectious Diseases P A was started in 2006 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Carlos Cohen for inquiries that concern South Florida Infectious Diseases P A by calling the company number (561) 381-3443, as your correspondence is most welcome. Additionally, the physical location of the single location of South Florida Infectious Diseases P A can be found at the coordinates 26.301821,-80.07791 as well as the street address 1237 Hillsboro Mile # 101 in Pompano Beach, Florida 33062.
For its online presence, you may visit South Florida Infectious Diseases P A’s website at and engage with its social media outlets through on Twitter and on Facebook.